Yuko Yamamoto

Dr. Yuko Yamamoto


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WSWakako Sakaguchi
Wakako Sakaguchi
NKNobuhisa Kubota
Nobuhisa Kubota
TSTomoko Shimizu
Tomoko Shimizu
JSJuri Saruta
Juri Saruta
SFShinya Fuchida
Shinya Fuchida
Tsukinoki KeiichiTsukinoki Keiichi
Tsukinoki Keiichi
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and furin, which promote entry of the virus into the host cell, have been identified as determinants of SARS-CoV-2 infection. Dorsal tongue and gingiva, saliva, and tongue coating samples were examined to determine the presence of these molecules in the oral cavity. Immunohistochemical analyses showed that ACE2 was expressed in the stratified squamous epithelium of the dorsal tongue and gingiva. TMPRSS2 was strongly expressed in stratified squamous epithelium in the keratinized surface layer and detected in the saliva and tongue coating samples via Western blot. Furin was localized mainly in the lower layer of stratified squamous epithelium and detected in the saliva but not tongue coating. ACE2, TMPRSS2, and furin mRNA expression was observed in taste bud-derived cultured cells, which was similar to the immunofluorescence observations. These data showed that essential molecules for SARS-CoV-2 infection were abundant in the oral cavity. However, the database analysis showed that saliva also contains many protease inhibitors. Therefore, although the oral cavity may be the entry route for SARS-CoV-2, other factors including protease inhibitors in the saliva that inhibit viral entry should be considered.

23 August 2017 in Gerodontology
Verified
Journal Article
Closed access
PDF file
YYYuko Yamamoto
Yuko Yamamoto
KFKazuhiro Fujino
Kazuhiro Fujino
JSJuri Saruta
Juri Saruta
TTToru Takahashi
Toru Takahashi
MTMasahiro To
Masahiro To
Tsukinoki KeiichiTsukinoki Keiichi
Tsukinoki Keiichi

17 August 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
YYYuko Yamamoto
Yuko Yamamoto
TTToru Takahahi
Toru Takahahi
MTMasahiro To
Masahiro To
YNYusuke Nakagawa
Yusuke Nakagawa
THTakashi Hayashi
Takashi Hayashi
Tsukinoki KeiichiTsukinoki Keiichi
Tsukinoki Keiichi
Salivary immunoglobulin A (IgA) serves as a major effector in mucosal immunity by preventing submucosal invasion of pathogens. However, the mechanism by which consumption of fermentable fibers increases IgA in saliva was not fully elucidated. This study investigated the effects of fructooligosaccharides (FOS) intake and time after feeding on IgA levels in the saliva and cecal digesta and on the concentration of short-chain fatty acids (SCFA) in the cecum in rats. Five-week-old rats were fed a fiber-free diet or a diet with 50 g/kg FOS for zero, one, four, and eight weeks. Ingestion of FOS at one and eight weeks led to a higher IgA flow rate of saliva per weight of submandibular gland tissue (p < 0.05), which positively correlated with the concentration of SCFA in the cecal digesta (rs = 0.86, p = 0.0006, n = 12), but showed no correlation with the concentration of IgA in the cecal digesta (rs = 0.15, p = 0.3, n = 48). These results suggested that ingestion of FOS increased salivary IgA secretion through high levels of SCFA in the large intestine, which was produced by fermentation of FOS. Thus, continuously ingesting FOS for more than one week could increase secretion of salivary IgA.

1 September 2009 in Brain and Development
Verified
Journal Article
Closed access
TSToshio Saito
Toshio Saito
YYYuko Yamamoto
Yuko Yamamoto
TMTsuyoshi Matsumura
Tsuyoshi Matsumura
HFHarutoshi Fujimura
Harutoshi Fujimura
SSSusumu Shinno
Susumu Shinno

17 July 2024 in Medicina
Verified
Journal Article
Open access
PDF file
TMTakaaki Matsui
Takaaki Matsui
Toshiya MorozumiToshiya Morozumi
Toshiya Morozumi
YYYuko Yamamoto
Yuko Yamamoto
TKTakashi Kobayashi
Takashi Kobayashi
RTRyo Takuma
Ryo Takuma
Motohiro KomakiMotohiro Komaki
Motohiro Komaki
Background and Objectives: The incidence of metabolic dysfunction-associated steatohepatitis (MASH)-related hepatocellular carcinoma (HCC) is increasing worldwide, alongside the epidemic of obesity and metabolic syndrome. Based on preliminary reports regarding the potential association of HCC and periodontitis, this study aimed to analyze the involvement of periodontal bacteria as well as the oral and intestinal bacterial flora in MASH-related HCC (MASH-HCC). Materials and Methods: Forty-one patients with MASH and nineteen with MASH-HCC participated in the study, completing survey questionnaires, undergoing periodontal examinations, and providing samples of saliva, mouth-rinsed water, feces, and peripheral blood. The oral and fecal microbiome profiles were analyzed by 16S ribosomal RNA sequencing. Bayesian network analysis was used to analyze the causation between various factors, including MASH-HCC, examinations, and bacteria. Results: The genus Fusobacterium had a significantly higher occupancy rate (p = 0.002) in the intestinal microflora of the MASH-HCC group compared to the MASH group. However, Butyricicoccus (p = 0.022) and Roseburia (p < 0.05) had significantly lower occupancy rates. The Bayesian network analysis revealed the absence of periodontal pathogenic bacteria and enteric bacteria affecting HCC. However, HCC directly affected the periodontal bacterial species Porphyromonas gingivalis, Tannerella forsythia, Fusobacterium nucleatum, and Prevotella intermedia in the saliva, as well as the genera Lactobacillus, Roseburia, Fusobacterium, Prevotella, Clostridium, Ruminococcus, Trabulsiella, and SMB53 in the intestine. Furthermore, P. gingivalis in the oral cavity directly affected the genera Lactobacillus and Streptococcus in the intestine. Conclusions: MASH-HCC directly affects periodontal pathogenic and intestinal bacteria, and P. gingivalis may affect the intestinal bacteria associated with gastrointestinal cancer.

11 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
YYYuko Yamamoto
Yuko Yamamoto
Toshiya MorozumiToshiya Morozumi
Toshiya Morozumi
TTToru Takahashi
Toru Takahashi
JSJuri Saruta
Juri Saruta
MTMasahiro To
Masahiro To
Tsukinoki KeiichiTsukinoki Keiichi
Tsukinoki Keiichi
Salivary immunoglobulin A (IgA) plays a vital role in preventing upper respiratory tract infections (URTI). In our previous study, we showed that the intake of carbohydrates increases the intestinal levels of short-chain fatty acids (SCFAs), which in turn increase salivary IgA levels. However, the mechanism underlying this phenomenon has not been fully elucidated. In this study, we investigated in rats the effect of polydextrose (PDX) ingestion on salivary IgA level and SCFA concentration in cecal digesta and the portal vein. Five-week-old rats were fed with a fiber-free diet (control) or with 40 g/kg of PDX for 28 days. Compared to the control, ingestion of PDX led to a higher salivary IgA flow rate (p = 0.0013) and a higher concentration of SCFAs in the portal vein (p = 0.004). These two data were positively correlated (rs = 0.88, p = 0.0002, n = 12). In contrast, the concentration of SCFAs in cecal digesta and cecal digesta viscosity were significantly lower following PDX ingestion, compared to the control (p = 0.008 and 0.05, respectively). These findings suggest that the ingestion of PDX increases the absorption rate of SCFAs in the intestine through PDX-induced fermentation, which is accompanied by an increase in SCFA levels in the blood, and ultimately leads to increased salivary IgA levels.